Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Wernecke

Showing results (1-10 of 68) with videos related to

Pageof 7
Sort By:
JAMA Internal Medicine|May 2, 2017
Dabigatran Compared With Rivaroxaban vs Warfarin-ReplyDavid J Graham, Michael Wernecke, Jeffrey A Kelman
Pharmacotherapy|April 15, 2025
Response to comment on "Use of proton pump inhibitors and risk of severe COVID-19: A case-control study in United States Medicare beneficiaries"Andrew D Mosholder, Michael Wernecke, David J Graham
The American Journal of Medicine|November 6, 2019
The ReplyDavid J Graham, Elande Baro, Michael Wernecke, et al.
Human Vaccines & Immunotherapeutics|April 12, 2018
Influenza vaccination coverage estimates in the fee-for service Medicare beneficiary population 2006 - 2016: Using population-based administrative data to support a geographic based near real-time toolAngela K Shen, Rob Warnock, Stephaeno Brereton, et al.
JAMA|September 8, 2018
Uptake of the Biologic Filgrastim and Its Biosimilar Product Among the Medicare PopulationSteven Kozlowski, Noy Birger, Stephaeno Brereton, et al.
Journal of General Internal Medicine|June 25, 2020
Uptake and Usage Patterns of Biosimilar Infliximab in the Medicare PopulationSteven Kozlowski, Natasha Flowers, Noy Birger, et al.
Journal of General Internal Medicine|June 1, 2022
Uptake and Competition Among Biosimilar Biological Products in the US Medicare Fee-for-Service PopulationSteven Kozlowski, Natasha Flowers, Andrew Kwist, et al.
JAMA Network Open|June 18, 2024
State Cannabis Legalization and Trends in Cannabis-Related Disorders in US Older Adults, 2017 to 2022Silvia Perez-Vilar, Pablo Freyria Duenas, Rose Radin, et al.
The Annals of Pharmacotherapy|November 29, 2013
Bleeding events following concurrent use of warfarin and oseltamivir by Medicare beneficiariesAndrew D Mosholder, Judith A Racoosin, Stephanie Young, et al.
Journal of Biopharmaceutical Statistics|March 20, 2020
Comparison of propensity score methods for pre-specified subgroup analysis with survival dataRima Izem, Jiemin Liao, Mao Hu, et al.
Pageof 7

Showing results (1-10 of 68) with videos related to

Sort By:
Pageof 7
JAMA Internal Medicine|May 2, 2017
Dabigatran Compared With Rivaroxaban vs Warfarin-ReplyDavid J Graham, Michael Wernecke, Jeffrey A Kelman
Pharmacotherapy|April 15, 2025
Response to comment on "Use of proton pump inhibitors and risk of severe COVID-19: A case-control study in United States Medicare beneficiaries"Andrew D Mosholder, Michael Wernecke, David J Graham
The American Journal of Medicine|November 6, 2019
The ReplyDavid J Graham, Elande Baro, Michael Wernecke, et al.
Human Vaccines & Immunotherapeutics|April 12, 2018
Influenza vaccination coverage estimates in the fee-for service Medicare beneficiary population 2006 - 2016: Using population-based administrative data to support a geographic based near real-time toolAngela K Shen, Rob Warnock, Stephaeno Brereton, et al.
JAMA|September 8, 2018
Uptake of the Biologic Filgrastim and Its Biosimilar Product Among the Medicare PopulationSteven Kozlowski, Noy Birger, Stephaeno Brereton, et al.
Journal of General Internal Medicine|June 25, 2020
Uptake and Usage Patterns of Biosimilar Infliximab in the Medicare PopulationSteven Kozlowski, Natasha Flowers, Noy Birger, et al.
Journal of General Internal Medicine|June 1, 2022
Uptake and Competition Among Biosimilar Biological Products in the US Medicare Fee-for-Service PopulationSteven Kozlowski, Natasha Flowers, Andrew Kwist, et al.
JAMA Network Open|June 18, 2024
State Cannabis Legalization and Trends in Cannabis-Related Disorders in US Older Adults, 2017 to 2022Silvia Perez-Vilar, Pablo Freyria Duenas, Rose Radin, et al.
The Annals of Pharmacotherapy|November 29, 2013
Bleeding events following concurrent use of warfarin and oseltamivir by Medicare beneficiariesAndrew D Mosholder, Judith A Racoosin, Stephanie Young, et al.
Journal of Biopharmaceutical Statistics|March 20, 2020
Comparison of propensity score methods for pre-specified subgroup analysis with survival dataRima Izem, Jiemin Liao, Mao Hu, et al.
Pageof 7